An overview of AI and Machine Learning methods: motivations, concepts, and examples

Autor: D Assouline, M-A Le Pogam, V Pittet

Publikováno v: European Journal of Public Health. 31

What is artificial intelligence? Big Data? Machine learning? It may seem very difficult to define these terms and identify their use in real life, aside from the hype surrounding them over the past ten years. All of these terms are interconnected - s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ef7a78a032200fb9f465c43b408bce53
https://doi.org/10.1093/eurpub/ckab164.569

Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group

Autor: Oana Brosteanu, Derek Crowther, J L Pater, D Assouline, P Jacobs, Richard I. Fisher, Volker Diehl, E Thompson, D. Hasenclever, Peter H. Wiernik, Richard T. Hoppe, Santiago Pavlovsky, A A Bartolucci, M Sextro, Peter A. Cassileth, Markus Loeffler

Publikováno v: Journal of Clinical Oncology. 16:818-829

DESIGN To perform a meta-analysis of all randomized trials that compared chemotherapy (CT) alone versus combined modality treatment (CT + radiotherapy [RT]) for which individual patient data could be made available. PATIENTS AND METHODS Data on 1,740

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e0dde65898926d143f206ec2513743
https://doi.org/10.1200/jco.1998.16.3.818

Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS

Autor: A. El Yamani, Roch Houot, J L Harousseau, Kamal Bouabdallah, Stéphane Courby, M. Ojeda Uribe, Nina Arakelyan, M. Alexis Vigier, Hervé Maisonneuve, Philippe Rodon, Caroline Dartigeas, S. Le Gouill, Remy Gressin, O. Tournilhac, Marie-Pierre Moles, Laurent Sutton, Luc Mathieu Fornecker, D. Assouline, Sylvie Caulet-Maugendre, Christiane Mounier

Publikováno v: Annals of Oncology
Annals of Oncology, 2012, 23 (6), pp.1555-61. ⟨10.1093/annonc/mdr450⟩
Annals of Oncology, Elsevier, 2012, 23 (6), pp.1555-61. ⟨10.1093/annonc/mdr450⟩
Annals of Oncology, Oxford University Press (OUP), 2012, 23 (6), pp.1555-61. ⟨10.1093/annonc/mdr450⟩

International audience; BACKGROUND: There is no consensual first-line chemotherapy for elderly patients with mantle cell lymphoma (MCL). The GOELAMS (Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang) group previously developed the (R)VAD+C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80680ac9758f397fa5d55a714413ee05
https://hal.science/hal-00744066

Lung cancer following Hodgkin′s disease: A case-control study

Autor: F. Landmark, P. Prior, Dorthe Pedersen, J. Bell, John M. Kaldor, Vera Pompe-Kirn, Nicholas Day, Sakari Karjalainen, D. Assouline, Matti Hakama, Pierre R. Band, Won Choi, R. A. Cartwright, V. Blair, H. Host, Marilyn Stovall, S. B. Sutcliffe, EA Clarke, Michel Henry-Amar, Maria Koch, Patricia Fraser, Annie Arslan

Publikováno v: International Journal of Cancer. 52:677-681

It is recognized that survivors of Hodgkin's disease are at a substantially increased risk of lung cancer. A collaborative group of population-based cancer registries and major treatment centers carried out a case-control study, in which 98 cases of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35491664a99f3dbd7b80e0d2ac0ebdbb
https://doi.org/10.1002/ijc.2910520502

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.